FDA Approves Zegalogue
FDA Approves Zegalogue (dasiglucagon) Injection for the Treatment of Severe Hypoglycemia in People with Diabetes Copenhagen, DK and Boston, MA, […]
Chile on Wednesday became the latest country to give emergency approval to China’s CoronaVac vaccine as it battles the coronavirus […] FDA Approves Klisyri (tirbanibulin) for the Treatment of Actinic Keratosis on the Face or Scalp BUFFALO, N.Y., Dec. 15, 2020 […] FDA Approves Qdolo (tramadol hydrochloride) Oral Solution for the Management of Severe Pain ATHENS, Ga., Sept. 8, 2020 /PRNewswire/ — […] (HealthDay)—A new drug to treat most cystic fibrosis patients has been approved by the U.S. Food and Drug Administration. Trikafta […] (HealthDay)—Venetoclax (VENCLEXTA) has been approved to treat adult patients with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma, the U.S. […] DURHAM, N.C.–(BUSINESS WIRE)–Mar. 12, 2019– Aerie Pharmaceuticals, Inc. (NASDAQ:AERI) (Aerie or the Company), an ophthalmic pharmaceutical company focused on the […] NEW YORK, December 21, 2018 (GLOBE NEWSWIRE) – Stemline Therapeutics, Inc. (NASDAQ:STML), a biopharmaceutical company focused on the development and […] RANCHO CUCAMONGA, Calif., Nov. 07, 2018 (GLOBE NEWSWIRE) — Amphastar Pharmaceuticals, Inc., (NASDAQ: AMPH) announced today that the U.S. Food […] THURSDAY, Nov. 8, 2018 — A new version of an over-the-counter asthma inhaler that was taken off the market in […]approves
Chile approves Chinese coronavirus vaccine
FDA Approves Klisyri
FDA Approves Qdolo
FDA approves new drug for most common form of cystic fibrosis
FDA approves venetoclax for chronic, small lymphocytic leukemia
FDA Approves Rocklatan
FDA Approves Elzonris (tagraxofusp-erzs), the First Treatment for Blastic Plasmacytoid Dendritic Cell Neoplasm and First CD123-Targeted Therapy
FDA Approves Newly Formulated OTC Primatene Mist (epinephrine) to Treat Mild Asthma
FDA Approves New Version of OTC Primatene Mist